Get Premium to unlock powerful stock data
XKRX:078160 (Korea, South)  
Medipost Co Ltd logo

Medipost Co Ltd

₩ 19750.00 (-2.95%) Jun 29
P/E:
At Loss
P/B:
2.09
Market Cap:
₩ 318.87B ($ 247.32M)
Enterprise V:
₩ 278.22B ($ 215.80M)
Volume:
98.05K
Avg Vol (2M):
90.84K
Also Trade In:
Volume:
98.05K
Market Cap ₩:
318.87B
Market Cap $:
247.32M
PE Ratio:
At Loss
Avg Vol (2-Month):
90.84K
Enterprise Value ₩:
278.22B
Enterprise Value $:
215.80M
PB Ratio:
2.09
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.
Name Current Vs Industry Vs History
Cash-To-Debt 2.37
Equity-to-Asset 0.57
Debt-to-Equity 0.19
Debt-to-EBITDA 3.77
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.14
Distress
Grey
Safe
Beneish M-Score -2.39
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.09
9-Day RSI 31.62
14-Day RSI 35.41
6-1 Month Momentum % 10.6
12-1 Month Momentum % -22.58

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.01
Quick Ratio 3.61
Cash Ratio 2.98
Days Inventory 143.79
Days Sales Outstanding 68.06
Days Payable 20.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.4

Financials

XKRX:078160's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₩) 57,213.426
EPS (TTM) (₩) -83
Beta 0.9
Volatility % 38.23
14-Day RSI 35.41
14-Day ATR (₩) 1234.066083
20-Day SMA (₩) 22650
12-1 Month Momentum % -22.58
52-Week Range (₩) 16750 - 32700
Shares Outstanding (Mil) 16.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Medipost Co Ltd Filings

Document Form Filing Date
No Filing Data